NIGP 94852: Infant Mortality Reduction Initiative

NIGP 94852 Infant Mortality Reduction Initiative is an Item code under which state and local governments procure medical devices, clinical staffing, and related services directly supporting newborn screening, early intervention, and maternal-child health programs. The scope of work spans manufacturing and supply of specialized medical collection devices (such as bloodspot screening cards), temporary clinical staffing across ancillary health professions to support screening and diagnostic services, and related program administration. Issuing bodies include state health departments (such as the Texas Department of State Health Services), county health systems, and affiliated procurement offices acting on behalf of clinical and public health agencies. The code reflects procurement driven by public health mandates rather than routine commodity or service acquisition; solicitations typically carry compliance requirements tied to FDA regulations, CGMP standards, quality assurance protocols, and state-specific program rules such as the Texas HUB Program.

Recent activity is concentrated in Texas and California. The Texas Department of State Health Services (through the Texas Health and Human Services Commission) posted an IFB in July 2026 for printing of newborn screening blood specimen collection devices—a seven-part medical form package with sequential numbering, barcodes, and QR codes, estimated at 776,400 units annually, with a response deadline of July 29, 2026 and a historical reference value of $870,173 for the prior contract period. The County of Santa Clara Health System issued an RFQ in July 2026 for temporary health professional staffing across thirteen ancillary clinical categories (audiology, diagnostic imaging, gastroenterology, medical social work, surgical services, therapy services, and others, excluding nursing and physician roles), with proposals due October 7, 2026, establishing a non-exclusive, multiple-award qualified-vendor pool with no guaranteed volume. Both solicitations underscore the program's focus on screening infrastructure and clinical capacity to support early identification and intervention.